MYCELX Technologies Corporation
MYX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.16 | 0.44 | -0.01 | 0.16 |
| FCF Yield | -20.52% | -6.64% | -55.92% | -21.37% |
| EV / EBITDA | -4.80 | -7.45 | -2.37 | 847.34 |
| Quality | ||||
| ROIC | -72.08% | -45.94% | -33.14% | -13.51% |
| Gross Margin | 27.41% | 35.67% | 44.30% | 38.63% |
| Cash Conversion Ratio | 0.79 | 0.30 | 0.67 | 2.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -21.21% | 8.76% | 12.17% | -10.71% |
| Free Cash Flow Growth | -82.24% | 65.84% | 7.06% | -129.09% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.09 | 0.17 | -87.42 |
| Interest Coverage | -350.23 | -370.22 | 0.00 | -62.83 |
| Efficiency | ||||
| Inventory Turnover | 0.89 | 2.05 | 1.49 | 1.20 |
| Cash Conversion Cycle | 513.65 | 166.75 | 293.44 | 343.06 |